COMPASS THERAPEUTICS, INC. (CMPX) Operating income 2018–2025
COMPASS THERAPEUTICS, INC. (CMPX) annual operating income history from SEC filings — each fiscal year as reported.
-$72.8MFY2025 · since FY2018: -$32,759 → -$72.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$72.8M | -28.6% |
| FY2024 | -$56.6M | -12.4% |
| FY2023 | -$50.4M | -20.9% |
| FY2022 | -$41.7M | +49.1% |
| FY2021 | -$81.9M | -194.4% |
| FY2020 | -$27.8M | -86528.3% |
| FY2019 | -$32,105 | +2.0% |
| FY2018 | -$32,759 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More CMPX financial trends
CMPX RevenueCMPX Net incomeCMPX Net marginCMPX Gross profitCMPX Gross marginCMPX Operating marginCMPX Operating cash flowCMPX Free cash flowCMPX Capital expendituresCMPX Return on equityCMPX Stock buybacksCMPX Dividends paidCMPX Total assetsCMPX Total liabilitiesCMPX Shareholders’ equityCMPX overview →